+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Gene Therapy"

Kallikrein Inhibitor - Pipeline Insight, 2024 - Product Thumbnail Image

Kallikrein Inhibitor - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
Toll-like-receptor-agonists - Pipeline Insight, 2024 - Product Thumbnail Image

Toll-like-receptor-agonists - Pipeline Insight, 2024

  • Drug Pipelines
  • January 2024
  • 60 Pages
  • Global
From
From
From
From
From
From
From
From
From
From
From
From
Genetic Cardiomyopathies Market Report and Forecast 2024-2032 - Product Thumbnail Image

Genetic Cardiomyopathies Market Report and Forecast 2024-2032

  • Report
  • September 2023
  • 200 Pages
  • Global
From
From
From
Loading Indicator

Gene therapy is a form of genomics that involves the introduction of genetic material into a patient's cells to treat or prevent a disease. It is a rapidly growing field of medicine, with the potential to revolutionize the treatment of genetic diseases. Gene therapy works by introducing a healthy gene into a patient's cells, replacing a defective gene or providing a missing gene. This can be done through a variety of methods, such as viral vectors, gene editing, and stem cell therapy. Gene therapy has the potential to provide long-term, curative treatments for a wide range of genetic diseases, including cancer, cystic fibrosis, and hemophilia. It is also being explored as a potential treatment for other conditions, such as Alzheimer's disease and Parkinson's disease. Gene therapy is a rapidly growing field, with many companies investing in research and development. Companies in the gene therapy market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Spark Therapeutics. Show Less Read more